DeutschNewstral
Article
vanguardngr.com on 2020-03-21 14:39
Coronavirus: NAFDAC only approved Chloroquine as clinical trial, says DG
Related news
- COVID-19: NAFDAC orders manufacturing of Chloroquine for clinical trialvanguardngr.com
- COVID-19: NAFDAC likely to lift ban on Chloroquine – NAFDAC DGvanguardngr.com
- COVID-19: NAFDAC orders manufacturing of chloroquine for clinical trialvanguardngr.com
Coronavirus: NAFDAC approves chloroquine production for clinical trialtribuneonlineng.com- COVID-19: NAFDAC has not approved any vaccines — DGvanguardngr.com
- BCOVID-19: Lagos to commence clinical trial of Chloroquine as NAFDAC orders emergency productionbusinessday.ng
- BNAFDAC approves chloroquine production for clinical trial businessday.ng
New NAFDAC DG assumes officepunchng.com- BNAFDAC says Chloroquine only effective for early stage of COVID-19 infectionbusinessday.ng
- COVID-19: Again, NAFDAC warns against use of Chloroquinetribuneonlineng.com
- NAFDAC mulls recruitment, says agency understaffed ― DGtribuneonlineng.com
- SBuhari reappoints Mojisola Adeyeye as NAFDAC DGsunnewsonline.com
- NAFDAC DG highlights dangers of bleaching creamspunchng.com
- COVID-19: We’ve not approved any vaccines for clinical trial – NAFDACvanguardngr.com
- NAFDAC DG advocates local manufacturing of drugs to achieve UHCvanguardngr.com
- Nigeria won’t take expired vaccines again —NAFDAC DG tribuneonlineng.com
New NAFDAC DG resumes workbusinessdayonline.com- I inherited N3.2bn debt upon assuming office — NAFDAC DGpunchng.com
- BPrevalence of substandard, falsified drugs in Nigeria alarming – NAFDAC DGbusinessday.ng